Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation

PLoS One. 2015 Nov 20;10(11):e0142921. doi: 10.1371/journal.pone.0142921. eCollection 2015.

Abstract

Transverse aortic constriction provokes a pro-inflammatory reaction and results in cardiac hypertrophy. Endogenous ligands contribute to cardiac hypertrophy via toll-like receptor (TLR)-4 binding. A lack of TLR4 signaling diminishes hypertrophy and inflammation. Wild type mice undergoing aortic constriction respond to a lipopolysaccharide second-hit stimulus with hyperinflammation. The objective of this study was to assess whether other second-hit challenges utilizing TLR ligands provoke a comparable inflammatory reaction, and to find out whether this response is absent in TLR4 deficient mice. Assuming that cardiac stress alters the expression of pattern recognition receptors we analyzed the effects of transverse aortic constriction and second-hit virulence factor treatment on TLR expression, as well as cytokine regulation. Wild type and Tlr4-/- mice were subjected to three days of TAC and subsequently confronted with gram-positive TLR2 ligand lipoteichoic acid (LTA, 15 mg/g bodyweight) or synthetic CpG-oligodesoxynucleotide 1668 thioate (20 nmol/kg bodyweight, 30 min after D-galactosamin desensitization) signaling via TLR9. Hemodynamic measurements and organ preservation were performed 6 h after stimulation. Indeed, the study revealed a robust enhancement of LTA induced pattern recognition receptor and cytokine mRNA expression and a LTA-dependent reduction of hemodynamic pressure in TAC wild type mice. Second-Hit treatment with CpG-ODNs led to similar results. However, second-hit effects were abolished in Tlr4-/- mice. In total, these data indicate for the first time that cardiac stress increases the inflammatory response towards both, gram-negative and gram-positive, TLR ligands as well as bacterial DNA. The decrease of the inflammatory response upon TLR2 and -9 ligand challenge in TAC Tlr4-/- mice demonstrates that a lack of TLR4 signaling does not only prevent left ventricular hypertrophy but also protects the mice from a cardiac stress induced hyperinflammatory reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / metabolism*
  • Aorta / pathology
  • Humans
  • Hypertrophy, Left Ventricular / genetics*
  • Hypertrophy, Left Ventricular / physiopathology
  • Inflammation / chemically induced
  • Inflammation / genetics*
  • Inflammation / pathology
  • Ligands
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / toxicity
  • Mice
  • Mice, Transgenic
  • Signal Transduction
  • Teichoic Acids / administration & dosage
  • Toll-Like Receptor 2 / biosynthesis
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 4 / genetics*
  • Toll-Like Receptor 4 / metabolism

Substances

  • Ligands
  • Lipopolysaccharides
  • Teichoic Acids
  • Tlr4 protein, mouse
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • lipoteichoic acid

Grants and funding

This work was supported by BA 1725/3-1, Deutsche Forschungsgemeinschaft (http://dfg.de/). GB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.